MiniMed Group, Inc.

MMED Nasdaq SEC CIK 2062583
Follow MiniMed Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2026 USD · US GAAP
Revenue, last quarter $837M +15.6% vs same quarter last year
Net income −$185M −7.6% vs same quarter last year
EPS, diluted -
Operating cash flow −$170M −304.8% vs same quarter last year
Revenue by quarter
$724M
$837M
Q4 25 Q4 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income3 fiscal years
  • Revenue
  • Net income
−$1B$0$1B$2B$3B$4BFY24FY25FY26
Show the numbers
YearRevenueNet income
FY26$3.1B−$333M
FY25$2.7B−$213M
FY24$2.5B−$112M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20%0%20%40%60%FY24FY25FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2654.2%−6.1%−10.7%
FY2556.3%−5.4%−7.8%
FY2458.2%−2.8%−4.5%
Free cash flowOperating cash flow minus capital expenditure
−$600M−$400M−$200M$0FY24FY25FY26
Show the numbers
YearFree cash flow
FY26−$420M
FY25−$53M
FY24−$107M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • MiniMed
  • Healthcare median
−60%−40%−20%0%FY24FY25FY26
Show the numbers
YearMiniMedHealthcare median
FY26−10.7%−11.1%
FY25−7.8%−30.8%
FY24−4.5%−47%